We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Here are 3 safe FTSE 100 dividend hero stocks I’d buy and hold forever

FTSE 100 dividend hero stocks consistently make payouts. Here are three examples that I think are safe bets for income investors.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Income investors have had it rough of late. The Covid-19 crisis has pushed 471 UK-listed companies to cut, suspend, or cancel their dividends, according to an analysis of data from dividenddata.co.uk. The FTSE 100, often viewed as a source of safe dividend stocks, has not been spared either; 52 of its members have cut payments to shareholders. But there are still FTSE 100 dividend hero shares out there for UK income investors to buy.

What makes a dividend hero? Well, I would say its a share that has at least maintained its regular dividend payments for a decade. AstraZeneca, Reckitt Benckiser, and RELX meet these criteria and have continued to make payments to shareholders throughout the Covid-19 pandemic.

Should you buy AstraZeneca Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Dividend safety first

In addition to being dividend heroes, the dividends these stocks are forecasted to pay also look safe. Safety is essential for investors who are relying on income (in the form of dividends) from their shareholdings, perhaps to support spending in retirement.

I am defining safety with forecasted dividend cover. Divide a stock’s earnings per share by its dividends per share, and you get dividend cover. Higher numbers are better. That’s because earnings can drop further before a stock pays more in dividends than it earns in net income, which makes a cut more likely. 

Stock Industry Current
Share Price
Dividend
Forecast
for 2021 
Earnings
Forecast
for 2021 
Dividend
Yield
Forecast
for 2021
Dividend
Cover
Forecast
for 2021
Forecasted
P/E Ratio
for 2021
AstraZeneca Healthcare 8,643p 219p 380p 2.5% 1.7 22.7
Reckitt
Benckiser
Consumer
Goods
7,358p 177p 313p 2.4% 1.8 23.8
RELX Consumer
Services
1,704p 48p 95p 2.8% 2.0 17.9

Based on analyst estimates for 2021 net income and dividends RELX, Reckitt, and AstraZeneca have the highest dividend cover numbers of all the dividend hero stocks, coming in at 2, 1.8, and 1.7 respectively. None of these numbers is above 2, which is normally where investors call a dividend safe. However, we are not in normal times. If an investor is looking for safe FTSE 100 dividend hero stocks, these are the best numbers out there.

Size and strength

Forecasts have a habit of being wrong. But, investors should take comfort from the fact that for the largest, most stable companies, they are generally more accurate. RELX, Reckitt, and AstraZeneca, being FTSE 100 members, are some of the largest UK-listed companies.

These three stocks are in the healthcare and consumer goods and services industries. Healthcare stocks, like AstraZeneca, benefit from non-discretionary revenues; drugs have to be bought no matter what. People tend to be quite brand loyal, which means consumer goods companies tend to have stable sales. That’s good for household goods titan Reckitt. Although RELX might appear to be a revenue risk – being in the consumer services industry – the bulk of its revenues are subscription-based, digital, mission-critical, and a fraction of its customers’ total costs. That means RELX’s revenues tend to be reliable.

Having stable and predictable revenues usually means the same for earnings and dividend payments. That is good for both forecast accuracy and payments to shareholders.

FTSE 100 dividend stocks

Alas, even relative safety comes at a price. RELX, Reckitt, and AstraZeneca shares have relatively low yields of 2.8%, 2.4%, and 2.5% respectively. For the investor relying on dividend payments, accepting a low dividend yield now might be judged as a trade-off that’s worth making.

So, there we have it: RELX, Reckitt, and AstraZeneca are three safe FTSE 100 dividend hero stocks I’d buy today and hold forever. 

James J. McCombie owns shares of RELX. The Motley Fool UK has recommended RELX. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female couple boarding their plane at the airport to go on holiday.
Investing Articles

Can the Rolls-Royce share price reach £15.97 by the end of August?

The Rolls-Royce share price has had a solid run in the last year. Muhammad Cheema takes a look at whether…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 1,200% in 5 years, here’s why Nvidia could still be a brilliant value stock

An exciting new announcement that could reshape the PC industry has just pushed Nvidia stock... well, just about nowhere really.

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How investing £4.50 a day could set you on the way to a £1,505 monthly second income

How can UK stocks with high dividend yields help investors earn a meaningful second income from the price of a…

Read more »

Investing Articles

Up 103% with a P/E of 261 — is this FTSE 100 stock still worth buying?

One FTSE 100 stock is quietly moving higher while most investors are still looking elsewhere — is the market missing…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

The smart money thinks AI stocks look risky — but is there still a chance to buy?

According to fund managers, the AI trade is getting crowded. But they still seem to think it’s the place to…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Barclays shares are 11% below their 52-week high. Could they be a bit of a bargain to consider?

Overpriced or one of the FTSE 100’s hidden gems? James Beard takes a closer look at how the market is…

Read more »

Stack of one pound coins falling over
Investing Articles

Down 65% but yielding 6.7% – is this beaten-down UK stock now a generational bargain?

Harvey Jones says this UK stock is one of the worst FTSE 100 performers but there are sound reasons to…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is this FTSE stock really 46% undervalued?

Analysts reckon this FTSE stock should be worth nearly 50% more. James Beard considers why there’s so much positivity surrounding…

Read more »